期刊
NATURE CHEMICAL BIOLOGY
卷 10, 期 8, 页码 626-U157出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.1551
关键词
-
资金
- Louis and Rachel Rudin Foundation
- Medical Scientist Training Program grant [NIGMS T32GM007739]
- US National Institutes of Health [GM98579]
- Starr Cancer Consortium [I6-A618]
To identify physiological targets of drugs and bioactive small molecules, we developed an approach, named DrugTargetSeqR, which combines high-throughput sequencing, computational mutation discovery and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-based genome editing. We applied this approach to ispinesib and YM155, drugs that have undergone clinical trials as anticancer agents, and uncovered mechanisms of action and identified genetic and epigenetic mechanisms likely to cause drug resistance in human cancer cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据